NATALIA DE LAS
HERAS JIMÉNEZ
Profesora titular de universidad
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2024
2023
2022
-
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
Haematologica, Vol. 107, Núm. 11, pp. 2675-2684
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433
2011
2009
2008
-
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Blood, Vol. 112, Núm. 10, pp. 4017-4023